−0.0280 USD
−2.37 M USD
0.00 USD
74.48 M
About Bioxytran, Inc.
Sector
Industry
CEO
David Platt
Website
Headquarters
Needham
Founded
2008
FIGI
BBG000P03775
BioXyTran, Inc. engages in the development, manufacture, and commercialization of therapeutic drugs designed to address hypoxia in humans, which is a lack of oxygen in tissues. Its product pipeline includes BXT-25, a drug designed to oxygenate ischemic (reduced blood flow) regions in the brain that suffered from hypoxia during a brain stroke, and BXT-252, which treats chronic wounds resulting from ischemia caused by occlusion of capillaries. The company was founded on June 9, 2008 and is headquartered in Needham, MA.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of BIXT is 0.1516 USD — it has decreased by −4.47% in the past 24 hours. Watch Bioxytran, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Bioxytran, Inc. stocks are traded under the ticker BIXT.
BIXT stock has risen by 12.38% compared to the previous week, the month change is a −4.53% fall, over the last year Bioxytran, Inc. has showed a 15.73% increase.
BIXT reached its all-time high on Jun 3, 2010 with the price of 874.9913 USD, and its all-time low was 0.0001 USD and was reached on Mar 31, 2021. View more price dynamics on BIXT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIXT stock is 15.87% volatile and has beta coefficient of −1.70. Track Bioxytran, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bioxytran, Inc. there?
Today Bioxytran, Inc. has the market capitalization of 13.49 M, it has decreased by −19.15% over the last week.
Yes, you can track Bioxytran, Inc. financials in yearly and quarterly reports right on TradingView.
BIXT net income for the last quarter is −1.35 M USD, while the quarter before that showed −512.27 K USD of net income which accounts for −164.24% change. Track more Bioxytran, Inc. financial stats to get the full picture.
No, BIXT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 25, 2025, the company has 3 employees. See our rating of the largest employees — is Bioxytran, Inc. on this list?
Like other stocks, BIXT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bioxytran, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bioxytran, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bioxytran, Inc. stock shows the neutral signal. See more of Bioxytran, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.